American Century Companies’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
II
American Century Companies's TNXP Position: Q2 2026 in Review
American Century Companies increased its Tonix Pharmaceuticals (TNXP) stake by 19% in Q2 2026, buying an estimated $31.1K and bringing the position to 15,258 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #2781.
American Century Companies first reported a position in TNXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $243K in Q3 2025. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.
- American Century Companies held 15,258 shares of Tonix Pharmaceuticals worth $195K as of Q2 2026.
- American Century Companies bought 2,408 Tonix Pharmaceuticals shares in Q2 2026, an estimated $31.1K.
- Tonix Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2781 holding.
- American Century Companies first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- American Century Companies's Tonix Pharmaceuticals position peaked at $243K in Q3 2025.
- 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.